Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
CLINICAL CHARACTERISTICS AND OUTCOMES OF BRAZILIAN PATIENTS WITH CASTLEMAN DISEASE: A BRAZILIAN MULTICENTRIC COHORT OF A RARE HEMATOLOGICAL DISORDER
A.A.G.S. Brandão; R.C.B. Melo; M. Bellesso; M.A.F. Aranha; H.S. Fernandes; D.L.C. Farias; P. Scheinberg; J. Pereira; E.M. Rego; V. Rocha;
Hematol Transfus Cell Ther. 2020;42 Supl 2:215-6
Erratum on ``Eltrombopag as first-line treatment in severe aplastic anemia: a cost-effectiveness analysis from the Brazilian public healthcare system perspective¿
M.A. Salvino; C. Bonfim; R.T. Calado; H. Kim; J.F. Bertinato; P. Scheinberg;
Hematol Transfus Cell Ther. 2022;44:305
IN VIVO EFFECTS OF ELTROMBOPAG ON THE EXPANSION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS IN APLASTIC ANAEMIA
B.Q. Oliveira; B.A.A.S. Lemos; L.F.B. Catto; M.F. Tellechea; P. Scheinberg; P.S. Scheucher; R.T. Calado;
Hematol Transfus Cell Ther. 2020;42 Supl 2:8-9